BlackRock Institutional Trust’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $5.9M | Buy |
349,005
+54,405
| +18% | +$919K | ﹤0.01% | 2660 |
|
2016
Q3 | $4.83M | Buy |
294,600
+25,613
| +10% | +$420K | ﹤0.01% | 2702 |
|
2016
Q2 | $4.07M | Buy |
268,987
+35,386
| +15% | +$536K | ﹤0.01% | 2771 |
|
2016
Q1 | $3.38M | Buy |
233,601
+52,341
| +29% | +$757K | ﹤0.01% | 2823 |
|
2015
Q4 | $5.13M | Buy |
181,260
+17,261
| +11% | +$489K | ﹤0.01% | 2705 |
|
2015
Q3 | $2.75M | Buy |
163,999
+46,312
| +39% | +$775K | ﹤0.01% | 2985 |
|
2015
Q2 | $3.09M | Buy |
117,687
+87,918
| +295% | +$2.31M | ﹤0.01% | 2943 |
|
2015
Q1 | $521K | Buy |
29,769
+5,776
| +24% | +$101K | ﹤0.01% | 3486 |
|
2014
Q4 | $417K | Sell |
23,993
-651
| -3% | -$11.3K | ﹤0.01% | 3516 |
|
2014
Q3 | $459K | Sell |
24,644
-5,233
| -18% | -$97.5K | ﹤0.01% | 3493 |
|
2014
Q2 | $546K | Buy |
+29,877
| New | +$546K | ﹤0.01% | 3529 |
|